All In Biotech

Free tool

FAERS Monitor: Mucinex

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021282 or its brand name (Mucinex, Guaifenesin). Reports on generic versions are filed under their own applications.

Reports

29,629

Serious

14,639

49% of reports

Hospitalization

7,657

Death reported

2,164

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective2,481
  • dyspnoea2,219
  • fatigue1,810
  • nausea1,771
  • diarrhoea1,677
  • pneumonia1,671
  • cough1,601
  • headache1,535
  • dizziness1,415
  • pain1,260
  • off label use993
  • vomiting953
  • death930
  • asthenia924
  • fall894

Reports by year received

View as table
YearReports
2004164
2005231
2006291
2007277
2008336
2009400
2010683
2011681
2012826
2013765
2014912
20152,136
20163,169
20172,376
20182,134
20192,119
20202,281
20211,420
20221,700
20231,801
20241,863
20252,159
2026902

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,024,530 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
coughSignal1,6014.13.93,733
pneumoniaSignal1,6713.73.53,289
dyspnoeaSignal2,2192.82.72,606
dizzinessSignal1,4152.01.9740
fall8941.91.8391
diarrhoea1,6771.81.8669
asthenia9241.71.6299
headache1,5351.71.7496
fatigue1,8101.71.6482
nausea1,7711.61.5401
pain1,2601.51.4185
vomiting9531.41.4130
drug ineffective2,4811.31.3224
off label use9930.80.849
death9300.80.769

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.